Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1845-1850

  Van Gestel, Anke M ^a   Haagsma, Cees J ^a   Van Riel, Piet L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FOOT RADIOGRAPHY; FUNCTIONAL ASSESSMENT; HAND RADIOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VALIDATION PROCESS;

ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; JOINTS; METHOTREXATE; REPRODUCIBILITY OF RESULTS; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0031715621     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K     Document Type: Article

References (9)

1. Van Riel PLCM. Provisional guidelines for measuring disease activity in RA clinical trials. Br J Rheumatol 1992;31:793-4.
2. Van Gestel AM, Prevoo MLL, van 't Hof MA, Rijswijk van MH, Putte van de LBA, Riel van PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/ International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34-40.
3. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D. Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
4. American College of Rheumatology Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Reduced joint counts in rheumatoid arthritis clinical trials. Arthritis Rheum 1994;37: 463-4.
5. Haagsma CJ, van Riel PLCM, de Jong AJL, van de Putte LBA. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double blind, 52 week clinical trial. Br J Rheumatol 1997;36:1082-8.
6. Van der Heijde DMFM, van Riel PLCM, van de Putte LBA. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine and sulfasalazine. Scand J Rheumatol 1990;19:407-12.
7. Van der Heijde DMFM, van Riel PLCM, Nuver-Zwart HH, Gribnau FWJ, van de Putte LBA. Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
8. Boers M, Verhoeven AC, Markusse HM, van de Laar MAFJ, Westhovens R, van Denderen JC, et al. Randomized comparison of combined step-down prednisone, methotrexate and sulfasalazine with sulfasalazine alone in early rheumatoid arthritis. Lancet 1997; 350:309-18.
9. Prevoo MLL, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified Disease Activity Scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.